Epipens are manufactured by two subsidiaries of Pfizer, King Pharmaceuticals and Meridian Medical Technologies, and sold by Mylan. According to the lawsuit filed by Rokita, Mylan's branded EpiPens took up to 98% of the epinephrine auto-injector market from at least 2011 through 2017.